Back to search results

Team Clinic for Type 2 Diabetes (TCT2) for Youth

This study is looking at whether "Shared Medical Appointments" are a good way to provide care for young people (ages 12-18) with Type 2 Diabetes. Shared Medical Appointments involve attending quarterly appointments with your clinician and participating in group activities that cover important topics. Researchers want to see if this approach is acceptable to patients and if it improves their well-being. You could be eligible if you receive care for Type 2 Diabetes at CHLA or UCSF, are 12-18 years old, speak English, and are taking medication for your diabetes. The study aims to enroll 160 participants and is currently unclear about its recruitment status.

Study design
This interventional study plans to enroll 160 participants. It compares Shared Medical Appointments to standard multidisciplinary team-based care.
What's involved
Participants will attend quarterly clinic appointments and group activities, and complete surveys over a one-year period.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for one year after starting the study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06923046

Implementation of Team Clinic for Type 2 Diabetes (TCT2)

Recruiting
NAAges 12–18InterventionalHealth services
Children's Hospital Los Angeles
~160 participants
Updated 2025-10-29 on ClinicalTrials.gov
What's tested:Standard of CareShared Medical Appointments

At a glance

Recruiting sites
1 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Average number of clinics attended over 1 year period to be recorded by Study Coordinator
Measured over 1 year
+2 more outcomes measured

Conditions

Type 2 Diabetes

Explore related trials

Type 2 Diabetes Mellitus

Where it's being run

2 sites across 1 states
California2

Study leadership

  • Lily Chao, MD · PRINCIPAL_INVESTIGATOR · Children's Hospital Los Angeles

Who to contact

Fatima Aguilar
[email protected]
323-361-4606
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Receives care for type 2 diabetes at either CHLA or UCSF
English speaking youth
Youth prescribed medication for type 2 diabetes
English or Spanish speaking caregivers
Age 12 to 18 years old at the time of enrollment
Willingness to attend clinic visits and participate in group session (if randomized to Team Clinic), complete surveys
Has a child between the ages of 12 and up to 18 at the time of enrollment who receives care for T2D in the endocrinology clinic at CHLA. The child must provide consent/assent to participate as a youth participant.
Speaks English of Spanish. Over 95% of our T2D population speaks one of those two languages. Our facilitator will be bilingual in English and Spanish. It is not feasible for the facilitator to also speak another language. Having a language interpreter for discussion groups will affect the dynamics and flow of the group session
Willingness to participate in group session (if their child is randomized to Team Clinic) and complete surveys.

Exclusion

Participants who are non-verbal or unable to participate in group activities and discussions
Pregnancy
Inability or unwillingness of individual or legal guardian/representative to give written informed assent/consent
Inability or unwillingness of individual to give written informed consent

What this trial measures

  • Average number of clinics attended over 1 year period to be recorded by Study Coordinator1 year

    Data collected is the number of patient visits to the clinic.

  • Change in HbA1c for patients from baseline to end of study1 year

    Patients' glycemic outcomes will be taken every session (Visit 0 (baseline) - Visit 4) over a one-year period

  • Clinic Satisfaction1 year

    Patient participants will complete satisfaction survey at the end of each visit using a 5-point Likert scale; "Strongly disagree" is 1, "disagree" is 2, "neutral" is 3, "agree" is 4, "strongly agree" is 5.